nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—ABCB1—peripheral nervous system neoplasm	0.253	1	CbGaD
Azelastine—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0595	0.102	CbGbCtD
Azelastine—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0509	0.0868	CbGbCtD
Azelastine—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0437	0.0747	CbGbCtD
Azelastine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0387	0.0662	CbGbCtD
Azelastine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0338	0.0577	CbGbCtD
Azelastine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0305	0.0521	CbGbCtD
Azelastine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0293	0.0501	CbGbCtD
Azelastine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0244	0.0417	CbGbCtD
Azelastine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0214	0.0365	CbGbCtD
Azelastine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0214	0.0365	CbGbCtD
Azelastine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0205	0.0349	CbGbCtD
Azelastine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0195	0.0334	CbGbCtD
Azelastine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0166	0.0283	CbGbCtD
Azelastine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0165	0.0282	CbGbCtD
Azelastine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0148	0.0253	CbGbCtD
Azelastine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.014	0.0239	CbGbCtD
Azelastine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0128	0.0219	CbGbCtD
Azelastine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0128	0.0219	CbGbCtD
Azelastine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0123	0.0211	CbGbCtD
Azelastine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0119	0.0203	CbGbCtD
Azelastine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0111	0.019	CbGbCtD
Azelastine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00956	0.0163	CbGbCtD
Azelastine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00912	0.0156	CbGbCtD
Azelastine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00877	0.015	CbGbCtD
Azelastine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00851	0.0145	CbGbCtD
Azelastine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00836	0.0143	CbGbCtD
Azelastine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0057	0.00973	CbGbCtD
Azelastine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00546	0.00933	CbGbCtD
Azelastine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00537	0.00917	CbGbCtD
Azelastine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00501	0.00855	CbGbCtD
Azelastine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00342	0.00583	CbGbCtD
Azelastine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000192	0.00119	CcSEcCtD
Azelastine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000192	0.00119	CcSEcCtD
Azelastine—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00119	CcSEcCtD
Azelastine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00118	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00019	0.00118	CcSEcCtD
Azelastine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00019	0.00118	CcSEcCtD
Azelastine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000188	0.00117	CcSEcCtD
Azelastine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000188	0.00117	CcSEcCtD
Azelastine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.00116	CcSEcCtD
Azelastine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.00115	CcSEcCtD
Azelastine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000186	0.00115	CcSEcCtD
Azelastine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.00115	CcSEcCtD
Azelastine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000186	0.00115	CcSEcCtD
Azelastine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000186	0.00115	CcSEcCtD
Azelastine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000185	0.00115	CcSEcCtD
Azelastine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000185	0.00115	CcSEcCtD
Azelastine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000184	0.00114	CcSEcCtD
Azelastine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000184	0.00114	CcSEcCtD
Azelastine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000183	0.00114	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000183	0.00114	CcSEcCtD
Azelastine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00113	CcSEcCtD
Azelastine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000182	0.00113	CcSEcCtD
Azelastine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000182	0.00113	CcSEcCtD
Azelastine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000181	0.00112	CcSEcCtD
Azelastine—Malaise—Etoposide—peripheral nervous system neoplasm	0.00018	0.00112	CcSEcCtD
Azelastine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.00112	CcSEcCtD
Azelastine—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00111	CcSEcCtD
Azelastine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000179	0.00111	CcSEcCtD
Azelastine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000179	0.00111	CcSEcCtD
Azelastine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000179	0.00111	CcSEcCtD
Azelastine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000178	0.0011	CcSEcCtD
Azelastine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000178	0.0011	CcSEcCtD
Azelastine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000178	0.0011	CcSEcCtD
Azelastine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.0011	CcSEcCtD
Azelastine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000177	0.0011	CcSEcCtD
Azelastine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000177	0.00109	CcSEcCtD
Azelastine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000175	0.00109	CcSEcCtD
Azelastine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000175	0.00109	CcSEcCtD
Azelastine—Rash—Topotecan—peripheral nervous system neoplasm	0.000175	0.00109	CcSEcCtD
Azelastine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000175	0.00108	CcSEcCtD
Azelastine—Cough—Etoposide—peripheral nervous system neoplasm	0.000174	0.00108	CcSEcCtD
Azelastine—Headache—Topotecan—peripheral nervous system neoplasm	0.000174	0.00108	CcSEcCtD
Azelastine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000174	0.00108	CcSEcCtD
Azelastine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000174	0.00108	CcSEcCtD
Azelastine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000174	0.00108	CcSEcCtD
Azelastine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000174	0.00108	CcSEcCtD
Azelastine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000174	0.00108	CcSEcCtD
Azelastine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000173	0.00108	CcSEcCtD
Azelastine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000173	0.00107	CcSEcCtD
Azelastine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000173	0.00107	CcSEcCtD
Azelastine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000173	0.00107	CcSEcCtD
Azelastine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000172	0.00107	CcSEcCtD
Azelastine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.00107	CcSEcCtD
Azelastine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000172	0.00107	CcSEcCtD
Azelastine—Pain—Vincristine—peripheral nervous system neoplasm	0.000172	0.00107	CcSEcCtD
Azelastine—Rash—Melphalan—peripheral nervous system neoplasm	0.000171	0.00106	CcSEcCtD
Azelastine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000171	0.00106	CcSEcCtD
Azelastine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.00106	CcSEcCtD
Azelastine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00017	0.00105	CcSEcCtD
Azelastine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000168	0.00104	CcSEcCtD
Azelastine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00103	CcSEcCtD
Azelastine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00103	CcSEcCtD
Azelastine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000166	0.00103	CcSEcCtD
Azelastine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.00102	CcSEcCtD
Azelastine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.00102	CcSEcCtD
Azelastine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000165	0.00102	CcSEcCtD
Azelastine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000165	0.00102	CcSEcCtD
Azelastine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000164	0.00102	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00102	CcSEcCtD
Azelastine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000164	0.00101	CcSEcCtD
Azelastine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000164	0.00101	CcSEcCtD
Azelastine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000163	0.00101	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000162	0.001	CcSEcCtD
Azelastine—Infection—Etoposide—peripheral nervous system neoplasm	0.000162	0.001	CcSEcCtD
Azelastine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.001	CcSEcCtD
Azelastine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000162	0.001	CcSEcCtD
Azelastine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000996	CcSEcCtD
Azelastine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00016	0.00099	CcSEcCtD
Azelastine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000159	0.000986	CcSEcCtD
Azelastine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000159	0.000986	CcSEcCtD
Azelastine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000159	0.000986	CcSEcCtD
Azelastine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000983	CcSEcCtD
Azelastine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000958	CcSEcCtD
Azelastine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000154	0.000955	CcSEcCtD
Azelastine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.000954	CcSEcCtD
Azelastine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000953	CcSEcCtD
Azelastine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000152	0.000943	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00094	CcSEcCtD
Azelastine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.000929	CcSEcCtD
Azelastine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000926	CcSEcCtD
Azelastine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000922	CcSEcCtD
Azelastine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00092	CcSEcCtD
Azelastine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000148	0.000919	CcSEcCtD
Azelastine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.000916	CcSEcCtD
Azelastine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000909	CcSEcCtD
Azelastine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000146	0.000907	CcSEcCtD
Azelastine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000906	CcSEcCtD
Azelastine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000145	0.000901	CcSEcCtD
Azelastine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000145	0.000898	CcSEcCtD
Azelastine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000144	0.000895	CcSEcCtD
Azelastine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000143	0.000888	CcSEcCtD
Azelastine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000886	CcSEcCtD
Azelastine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.000886	CcSEcCtD
Azelastine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000142	0.00088	CcSEcCtD
Azelastine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000141	0.000872	CcSEcCtD
Azelastine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000141	0.000871	CcSEcCtD
Azelastine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000139	0.000864	CcSEcCtD
Azelastine—Pain—Etoposide—peripheral nervous system neoplasm	0.000139	0.000864	CcSEcCtD
Azelastine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000863	CcSEcCtD
Azelastine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000856	CcSEcCtD
Azelastine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000856	CcSEcCtD
Azelastine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000138	0.000853	CcSEcCtD
Azelastine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000851	CcSEcCtD
Azelastine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000847	CcSEcCtD
Azelastine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000839	CcSEcCtD
Azelastine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000838	CcSEcCtD
Azelastine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000833	CcSEcCtD
Azelastine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000134	0.000833	CcSEcCtD
Azelastine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000134	0.000829	CcSEcCtD
Azelastine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000133	0.000826	CcSEcCtD
Azelastine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000133	0.000825	CcSEcCtD
Azelastine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000823	CcSEcCtD
Azelastine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.000816	CcSEcCtD
Azelastine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.000815	CcSEcCtD
Azelastine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000813	CcSEcCtD
Azelastine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.000811	CcSEcCtD
Azelastine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000799	CcSEcCtD
Azelastine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000129	0.000799	CcSEcCtD
Azelastine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000129	0.000799	CcSEcCtD
Azelastine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000799	CcSEcCtD
Azelastine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000793	CcSEcCtD
Azelastine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000128	0.000793	CcSEcCtD
Azelastine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000791	CcSEcCtD
Azelastine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000791	CcSEcCtD
Azelastine—Rash—Vincristine—peripheral nervous system neoplasm	0.000127	0.000786	CcSEcCtD
Azelastine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000127	0.000786	CcSEcCtD
Azelastine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000783	CcSEcCtD
Azelastine—Headache—Vincristine—peripheral nervous system neoplasm	0.000126	0.000781	CcSEcCtD
Azelastine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000775	CcSEcCtD
Azelastine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000771	CcSEcCtD
Azelastine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000769	CcSEcCtD
Azelastine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000768	CcSEcCtD
Azelastine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000122	0.000755	CcSEcCtD
Azelastine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000745	CcSEcCtD
Azelastine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00012	0.000744	CcSEcCtD
Azelastine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000119	0.000741	CcSEcCtD
Azelastine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00074	CcSEcCtD
Azelastine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000739	CcSEcCtD
Azelastine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000734	CcSEcCtD
Azelastine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000732	CcSEcCtD
Azelastine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000117	0.000725	CcSEcCtD
Azelastine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000115	0.000715	CcSEcCtD
Azelastine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000711	CcSEcCtD
Azelastine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000701	CcSEcCtD
Azelastine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000695	CcSEcCtD
Azelastine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000695	CcSEcCtD
Azelastine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000112	0.000691	CcSEcCtD
Azelastine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000689	CcSEcCtD
Azelastine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000685	CcSEcCtD
Azelastine—Tension—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000681	CcSEcCtD
Azelastine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00068	CcSEcCtD
Azelastine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000674	CcSEcCtD
Azelastine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000671	CcSEcCtD
Azelastine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000108	0.000668	CcSEcCtD
Azelastine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000655	CcSEcCtD
Azelastine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000654	CcSEcCtD
Azelastine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000644	CcSEcCtD
Azelastine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000104	0.000642	CcSEcCtD
Azelastine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000638	CcSEcCtD
Azelastine—Rash—Etoposide—peripheral nervous system neoplasm	0.000103	0.000637	CcSEcCtD
Azelastine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000103	0.000636	CcSEcCtD
Azelastine—Headache—Etoposide—peripheral nervous system neoplasm	0.000102	0.000633	CcSEcCtD
Azelastine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.00063	CcSEcCtD
Azelastine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000629	CcSEcCtD
Azelastine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000626	CcSEcCtD
Azelastine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000624	CcSEcCtD
Azelastine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000623	CcSEcCtD
Azelastine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000621	CcSEcCtD
Azelastine—Palpitations—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000613	CcSEcCtD
Azelastine—Cough—Epirubicin—peripheral nervous system neoplasm	9.77e-05	0.000606	CcSEcCtD
Azelastine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000605	CcSEcCtD
Azelastine—Nausea—Etoposide—peripheral nervous system neoplasm	9.68e-05	0.0006	CcSEcCtD
Azelastine—Hypertension—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000599	CcSEcCtD
Azelastine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000596	CcSEcCtD
Azelastine—Chest pain—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.000591	CcSEcCtD
Azelastine—Myalgia—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.000591	CcSEcCtD
Azelastine—Agitation—Doxorubicin—peripheral nervous system neoplasm	9.52e-05	0.00059	CcSEcCtD
Azelastine—Anxiety—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000589	CcSEcCtD
Azelastine—Discomfort—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000584	CcSEcCtD
Azelastine—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000579	CcSEcCtD
Azelastine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.32e-05	0.000578	CcSEcCtD
Azelastine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.31e-05	0.000577	CcSEcCtD
Azelastine—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000571	CcSEcCtD
Azelastine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000567	CcSEcCtD
Azelastine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.000566	CcSEcCtD
Azelastine—Infection—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.000563	CcSEcCtD
Azelastine—Cough—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.00056	CcSEcCtD
Azelastine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.000554	CcSEcCtD
Azelastine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	8.92e-05	0.000553	CcSEcCtD
Azelastine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	0.000547	CcSEcCtD
Azelastine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	0.000547	CcSEcCtD
Azelastine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000545	CcSEcCtD
Azelastine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.00054	CcSEcCtD
Azelastine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000535	CcSEcCtD
Azelastine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000528	CcSEcCtD
Azelastine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000524	CcSEcCtD
Azelastine—Infection—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.000521	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000516	CcSEcCtD
Azelastine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.25e-05	0.000511	CcSEcCtD
Azelastine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000509	CcSEcCtD
Azelastine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.14e-05	0.000505	CcSEcCtD
Azelastine—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.000504	CcSEcCtD
Azelastine—Fatigue—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.000488	CcSEcCtD
Azelastine—Pain—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000484	CcSEcCtD
Azelastine—Constipation—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000484	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000477	CcSEcCtD
Azelastine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000471	CcSEcCtD
Azelastine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.54e-05	0.000467	CcSEcCtD
Azelastine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000467	CcSEcCtD
Azelastine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.51e-05	0.000466	CcSEcCtD
Azelastine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.47e-05	0.000463	CcSEcCtD
Azelastine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000452	CcSEcCtD
Azelastine—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000448	CcSEcCtD
Azelastine—Pain—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000448	CcSEcCtD
Azelastine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000448	CcSEcCtD
Azelastine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000448	CcSEcCtD
Azelastine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000432	CcSEcCtD
Azelastine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000429	CcSEcCtD
Azelastine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000417	CcSEcCtD
Azelastine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000414	CcSEcCtD
Azelastine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000414	CcSEcCtD
Azelastine—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.000406	CcSEcCtD
Azelastine—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000401	CcSEcCtD
Azelastine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.25e-05	0.000388	CcSEcCtD
Azelastine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	0.000386	CcSEcCtD
Azelastine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000376	CcSEcCtD
Azelastine—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000375	CcSEcCtD
Azelastine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000371	CcSEcCtD
Azelastine—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.00036	CcSEcCtD
Azelastine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.78e-05	0.000359	CcSEcCtD
Azelastine—Rash—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.000357	CcSEcCtD
Azelastine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000357	CcSEcCtD
Azelastine—Headache—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000355	CcSEcCtD
Azelastine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000347	CcSEcCtD
Azelastine—Nausea—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000336	CcSEcCtD
Azelastine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000333	CcSEcCtD
Azelastine—Rash—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.00033	CcSEcCtD
Azelastine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.00033	CcSEcCtD
Azelastine—Headache—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.000328	CcSEcCtD
Azelastine—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000311	CcSEcCtD
